Lee's Summit Office
Walk-In Hours available for Established Patients at Main and Lee's Summit locations
Our Mission Is: To be the preeminent caregivers for patients with allergic diseases and asthma.
The KCAA research department
The research department at KCAA has been conducting clinical research trials for over 20 years and boasts staff members with years of research experience. Jeffrey Wald, M.D. and Mark Neustrom, D.O. currently are the lead investigators for research studies at KCAA. All of our physicians and providers are committed to research excellence. Over 250 clinical trials have been completed in the areas of seasonal and perennial allergic rhinitis, asthma, allergic asthma, GERD, hereditary angioedema, chronic sinusitis, eczema, hives, allergy immunotherapy, seasonal flu and flu vaccines.
Participating in clinical research trials has allowed KCAA to play an integral part in helping organizations worldwide, gather crucial information about treating various conditions. Some studies conducted at KCAA contributed to the development and approval of common allergy and asthma medication like Symbicort, Allegra, Astepro Omnaris, Singulair and Xolair. Several trials, including immunotherapy delivered under the tongue (sublingually), have been perfomed at KCAA. These include patients allergic to ragweed and grass.
KCAA volunteers gain the added benefit of taking an active role in their health care, gain access to treatments before they become widely available, receive expert medical care at no cost and help others by contributing to medical research. Qualified participants also may be eligible to be reimbursed for their time.
Participants in KCAA trials are given detailed information about how the trial will be conducted, who qualifies and the potential benefits and risks of participation. The health of each volunteer participant is checked before entering the study and closely monitored throughout the study. Trials conducted by KCAA are also closely observed by the independent Institutional Review Boards (IRBs) and the Food and Drug Administration (FDA) to ensure the safety of all who volunteer.
If you are interested in participating in a clinical trial, please contact any KCAA research coordinator at (913) 345-2383 or email firstname.lastname@example.org.
Below is a list of the available studies with KCAA. If you are interested in a study, click on the link to read more about it. If you would like to participate in that study, you will then be presented with the opportunity to have a research coordinator contact you by clicking on the "sign up" tab at the bottom of the page. Not all studies being conducted are listed below, so please call the Research Department to obtain a complete listing. If you have questions about our studies, please review the Research FAQ
To schedule an appointment at any one of our three offices, call 913-491-5501
We offer our patients convenient office hours Monday through Saturday. New patients must schedule an appointment in advance and can usually be seen the same week. More information for new patients can be found HERE.
NOTE: New patients being skin tested must stay off antihistamines for four days prior to their appointment.
How much rescue inhaler (albuterol or xopenex) use is too much?
Be sure to save our website in your favorites, www.kcallergy.com